GERN vs. UHS

In the year-to-date period, GERN achieves a 1.69% return, which is significantly higher than UHS's 0.14% return. Over the past 10 years, GERN has underperformed UHS with an annualized return of 1.03%, while UHS has yielded a comparatively higher 5.60% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Geron Corporation (GERN) and Universal Health Services, Inc. (UHS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current GERN Sharpe Ratio is 0.62, which is comparable to the UHS Sharpe Ratio of 0.55. The chart below compares the historical Sharpe Ratios of GERN and UHS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

GERN has not paid dividends to shareholders, while UHS's dividend yield for the trailing twelve months is around 0.45%.

The maximum GERN drawdown since its inception was -98.65%, which is greater than UHS's maximum drawdown of -60.27%. Use the drawdown chart below to compare losses from any high point for GERN and UHS. For additional features, visit the drawdowns tool.

Geron Corporation (GERN) has a higher volatility of 10.89% compared to Universal Health Services, Inc. (UHS) at 5.25%. This indicates that GERN's price experiences larger fluctuations and is considered to be riskier than UHS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Geron Corporation and Universal Health Services, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.